Showing 4831-4840 of 10638 results for "".
Cell Death and Differentiation: A Novel Treatment of Cystic Fibrosis Acting On-Target
https://reachmd.com/programs/Audioabstracts/cell-death-differentiation-novel-treatment-cystic-fibrosis-acting-target/8219/A novel treatment of cystic fibrosis acting on-target.Selecting the Right Contraception for the Dyslipidemic Woman
https://reachmd.com/programs/lipid-luminations/selecting-right-contraception-for-the-dyslipidemic-woman/8127/Dr. Robert Wild discusses types of dyslipidemia that clinicans may see in women of child bearing age, particularly those using hormonal contraception.Patients Prefer to Receive Abortion Care via Telemedicine vs In-Clinic Visits
https://reachmd.com/programs/advances-in-womens-health/patients-prefer-to-receive-abortion-care-via-telemedicine-vs-in-clinic-visits/15365/A recent study presented at the 2023 ACOG Annual Meeting showed that patients prefer telemedicine abortion care compared to in-office visits.Challenging the Standard of Care in NSCLC: Findings from the TROPION-Lung01 Study
https://reachmd.com/programs/project-oncology/challenging-the-standard-of-care-in-nsclc-findings-from-the-tropion-lung01-study/16360/What role might datopotamab deruxtecan play in treating patients with non-small cell lung cancer? Find out with this recap of a recent study.How to Achieve Patient Satisfaction Through Culturally Aware Communication
https://reachmd.com/programs/lifelong-learning/how-to-achieve-patient-satisfaction-through-culturally-aware-communication/10019/Drs. Aboulsoud & Uhlmann enlighten healthcare teams on how to achieve patient satisfaction through cultural competence and cultural awareness.New Research Suggests Increased Number of IVF Cycles Can Be Beneficial
https://reachmd.com/programs/the-jama-report/new-research-suggests-increased-number-ivf-cycles-can-be-beneficial/7864/[Read the Article] Women facing infertility often turn to in vitro fertilization (IVF). Although IVF technology has improved, there is still a widely held belief that if a woman doesn't experience a successful live birth after three or four IVF cycles, her chances of a successful live birth are veryThe Lancet: Postural Modification to the Standard Valsalva Maneuver for Emergency Treatment of Supraventricular Tachycardias (REVERT)
https://reachmd.com/programs/Audioabstracts/lancet-postural-modification-standard-valsalva-maneuver-emergency-treatment-svt-revert/7633/Postural modification to the standard Valsalva manoeuvre for emergency treatment of supraventricular tachycardias (REVERT): a randomised controlled trial Andrew Appelboam, FRCEM, Adam Reuben, FRCEM, Clifford Mann, FRCEM, James Gagg, FRCEM, Prof Paul Ewings, PhD, Andrew Barton, MSc, Trudie Lobban, MRSuprachoroidal Steroids in Patients With a History of Glaucoma and Ocular Hypertension
https://reachmd.com/clinical-practice/ophthalmology/suprachoroidal-steroids-in-patients-with-a-history-of-glaucoma-and-ocular-hypertension/54287/Using steroids in patients with a history of glaucoma, ocular hypertension, or steroid response requires careful monitoring and risk assessment. Could a suprachoroidal route of administration mitigate risk? Maria Berrocal, MD, invites Danny Mammo, MD, to share details from a study he and his colleagEfficacy of Obicetrapib Across Diverse Background Lipid-Lowering Regimens: Pooled BROADWAY & BROOKLYN Analyses
https://reachmd.com/clinical-practice/cardiology/efficacy-of-obicetrapib-across-diverse-background-lipid-lowering-regimens-pooled-broadway-brooklyn-analyses/36582/Efficacy of Obicetrapib Across Diverse Background Lipid-Lowering Regimens: Pooled BROADWAY & BROOKLYN AnalysesReducing Patient Time Burden in HER2+ Breast Cancer with Subcutaneous Trastuzumab/Pertuzumab
https://reachmd.com/programs/project-oncology/reducing-patient-time-burden-in-her2-breast-cancer-with-subcutaneous-trastuzumabpertuzumab/32996/A time and motion substudy within the ADEPT trial demonstrates that subcutaneous administration of trastuzumab and pertuzumab significantly reduces treatment time compared to intravenous delivery in patients with early-stage HER2-positive breast cancer. These time savings could help enhance patient